Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Maccubbin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncology Research|January 1, 1994
Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric studyG Zaleskis, R L Ho, P Diegelman, et al.
International Journal of Clinical Practice|October 10, 2013
The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapyT Rhodes, J M Norquist, C McCrary Sisk, et al.
International Journal of Clinical Practice|June 4, 2010
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemiaS Shah, R Ceska, B Gil-Extremera, et al.
International Journal of Clinical Practice|January 27, 2009
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemiaD Maccubbin, H E Bays, A G Olsson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncology Research|January 1, 1994
Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric studyG Zaleskis, R L Ho, P Diegelman, et al.
International Journal of Clinical Practice|October 10, 2013
The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapyT Rhodes, J M Norquist, C McCrary Sisk, et al.
International Journal of Clinical Practice|June 4, 2010
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemiaS Shah, R Ceska, B Gil-Extremera, et al.
International Journal of Clinical Practice|January 27, 2009
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemiaD Maccubbin, H E Bays, A G Olsson, et al.
Pageof 2